Results 171 to 180 of about 2,257,568 (316)

Body surface area: a predictor of response to red blood cell transfusion

, 2016
Louise Man,1 H Raymond Tahhan1–3 1Department of Internal Medicine, Eastern Virginia Medical School, 2Department of Pathology, Eastern Virginia Medical School, 3Department of Pathology, Sentara Norfolk General Hospital, Norfolk, VA, USA Abstract: A ...
Man L, Tahhan HR
core  

Simulation and Response Surface Methodology for Predicting Mass Transfer in Coaxial Electrospun Core-Shell Fibers. [PDF]

Micromachines (Basel)
Chen X, Shu W, Zhang R, Huang S, Zhang X.   +4 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Optimization of Ultrasound-Assisted Extraction Conditions for Phenolic Content and Antioxidant Activity in Green Mango Peel Using Response Surface Methodology. [PDF]

Food Sci Nutr
Rohman MA, Rahman MN, Halim MA, Sohany M, Mahomud MS.   +4 more
europepmc   +1 more source

Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi, Kenichiro Taira, Masanori Kurihara, Kenji Ishibashi, Kenji Ishii, Fumio Suzuki, Aya Midori Tokumaru, Makoto Hara, Atsushi Iwata   +8 more
wiley   +1 more source

Correction: Synthesis of a metal-organic framework with red mud for organic pollutant adsorption using response surface methodology for sustainable chemistry. [PDF]

Sci Rep
Chegeni M, Chegeni M, Zade GE.
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Experimental petroleum resin production and optimization using response surface modeling. [PDF]

Sci Rep
Rostami MT, Shahverdi H, Javanbakht V, Chermahini AN, Fakhar A.   +4 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

The Effect of Ultraviolet Modification on the Performance of Polyamide Fiber-Reinforced Cement Mortars: Optimization and Characterization Using Response Surface Methodology. [PDF]

Polymers (Basel)
Akarsu Özenç A, Mardani A, Özenç F, Eren S.   +3 more
europepmc   +1 more source